financetom
Business
financetom
/
Business
/
Equifax's Q2 Non-GAAP Earnings, Revenue Rise; Updates 2025 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Equifax's Q2 Non-GAAP Earnings, Revenue Rise; Updates 2025 Guidance
Jul 22, 2025 4:13 AM

06:49 AM EDT, 07/22/2025 (MT Newswires) -- Equifax ( EFX ) reported Q2 non-GAAP earnings Tuesday of $2 per diluted share, up from $1.82 a year earlier.

Analysts polled by FactSet expected $1.92.

Operating revenue for the quarter ended June 30 was $1.54 billion compared with $1.43 billion a year earlier.

Analysts surveyed by FactSet expected $1.51 billion.

For Q3, the company expects adjusted earnings of $1.87 to $1.97 per share on revenue of $1.51 billion to $1.54 billion. Analysts surveyed by FactSet expect adjusted earnings of $1.99 per share on revenue of $1.53 billion.

The company narrowed its 2025 adjusted earnings guidance to $7.33 to $7.63 per share from $7.25 to $7.65. Analysts surveyed by FactSet expect $7.62. It raised its annual reported revenue guidance to $5.97 billion to $6.04 billion from $5.91 billion to $6.03 billion. Analysts surveyed by FactSet expect $6.01 billion.

Shares of the company were up 2.4% in Tuesday's premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Artivion Insider Sold Shares Worth $1,568,802, According to a Recent SEC Filing
Artivion Insider Sold Shares Worth $1,568,802, According to a Recent SEC Filing
Nov 14, 2025
12:13 PM EST, 11/14/2025 (MT Newswires) -- James P Mackin, President & CEO, on November 13, 2025, sold 34,210 shares in Artivion ( AORT ) for $1,568,802. Following the Form 4 filing with the SEC, Mackin has control over a total of 800,993 common shares of the company, with 800,993 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/784199/000162828025052264/xslF345X05/wk-form4_1763140154.xml Price: 44.61, Change: -0.98,...
Artivion Insider Sold Shares Worth $264,188, According to a Recent SEC Filing
Artivion Insider Sold Shares Worth $264,188, According to a Recent SEC Filing
Nov 14, 2025
12:15 PM EST, 11/14/2025 (MT Newswires) -- Jean F Holloway, Senior Vice President, General Counsel, on November 13, 2025, sold 5,761 shares in Artivion ( AORT ) for $264,188. Following the Form 4 filing with the SEC, Holloway has control over a total of 163,408 common shares of the company, with 163,408 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/784199/000162828025052262/xslF345X05/wk-form4_1763140100.xml Price: 44.61,...
Kura Scores A Big Win As FDA Approves Its New Leukemia Pill
Kura Scores A Big Win As FDA Approves Its New Leukemia Pill
Nov 14, 2025
On Thursday, the U.S. Food and Drug Administration granted full approval to Komzifti (ziftomenib), developed by Kura Oncology Inc. ( KURA ) and Kyowa Kirin Co., Ltd., for treating relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible NPM1 mutation. Komzifti is the first and only once-daily, oral menin inhibitor approved for R/R NPM1-mutated (NPM1-m) AML, a type...
Bloom Energy Stock Jumps Friday: What Investors Need To Know
Bloom Energy Stock Jumps Friday: What Investors Need To Know
Nov 14, 2025
Bloom Energy Corp ( BE ) shares are trading higher Friday, recovering ground after a sharp pullback during the previous session. The fuel-cell maker is attracting buyers stepping in to capitalize on Thursday's dip, which appears to have been driven by broader market volatility rather than company-specific negatives. Here’s what investors need to know. BE stock is racing ahead of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved